Home › Ulcerative Colitis › Indiana
Ulcerative Colitis clinical trials in Indiana
11 studies for Ulcerative Colitis are looking for participants at sites in Indiana.
Cities in Indiana
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, New Albany
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT07415044Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Indiana University Health University Hospital, Indianapolis
- Gastroenterology Health Partners, New Albany
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Health Partners, New Albany
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT07186101A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Riley Hospital for Children, Indianapolis
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Nov 3, 2026 · NCT06663332A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Riverview Health, Westfield
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Oct 28, 2026 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Health Partners /ID# 284145, New Albany
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07697456A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Investigational Drug Services - Riley Hospital, Indianapolis
- IU Health North Hospital, Indianapolis
- Riley Hospital for Children at IU Health, Indianapolis
RecruitingPhase 2
Ages 2 to 11 · All sexes · Updated Oct 26, 2026 · NCT07470879An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, PLLC - Site Number: 8400100, New Albany
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 23, 2026 · NCT07184996A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0100, Indianapolis
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Oct 20, 2026 · NCT05076175A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, PLLC - New Albany - Site Number: 8400100, New Albany
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 16, 2026 · NCT07185009Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 003, Indianapolis
RecruitingPhase 4
Ages 5 to 17 · All sexes · Updated Sep 16, 2025 · NCT04314375From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.